LabCorp to Use Affymetrix Technology for Molecular Cytogenetic Service Offering

Teaser:

Affymetrix Inc. (Nasdaq:AFFX) announced today that its GeneChip(R) technology will form the foundation of the new molecular cytogenetic service offering by Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH). LabCorp, an industry leader in molecular diagnostic testing, is making the service available to customers across the United States.

Source: Affymetrix